CEO‑Level Buy‑Back: Omeros Chairman Greg Demopulos Buys 400,000 Shares, Betting on Breakthrough Pipeline and Share Rally
CEO‑level purchase of 400k Omeros shares signals confidence as the drug’s clinical momentum rises—what this means for investors.
3 minutes to read